LTR Medical is excited to announce that it has recently gained TGA approval for Twitchview – an objective train-of-four (ToF) monitor for neuromuscular blockade and the first stand-alone EMG (electromyographic) based technology.
TwitchView enables healthcare providers to deliver improved patient care and cost saving benefits by eliminating guesswork in the assessment of neuromuscular blocks, thereby improving patient recovery.
With EMG Monitoring described as the gold standard for monitoring neuromuscular blockade, TwitchView has the potential to make a significant impact as the first stand-alone EMG based monitor available on the market.
Danny Zanardo, VP Commercial LTR Medical, commented:
“We believe the TwitchView is a vital addition to modern anaesthesia management and that it stands alone amongst train-of-four (ToF) monitors to safely improve patient recovery. The team at LTR Medical are looking forward to launching TwitchView to Anaesthetists and patients in the Australian and New Zealand Markets.”
Justin Hulvershorn, MD, PhD and CEO of Blink, commented:
We’ve had an overwhelmingly positive response from anaesthesiologists in the U.S. looking to transition from older peripheral nerve stimulators to quantitative ToF monitors. Based on that experience, we strongly believe TwitchView will rapidly find its way into operating rooms all over the world.”
About TwitchView™
TwitchView provides quantitative train of four (ToF) monitoring which eliminates the guesswork in the assessment of neuromuscular blockade. Validated electromyography (EMG) with TwitchView provides continuous measurements to inform clinical decisions and the TOF ratio needed to confirm patient recovery.
The TwitchView trend plot displays the individual patient’s progression of block and recovery. Patient’s specific pharmaco-dynamics inform the precise dosing of neuromuscular blockade and reversal agents. With TwitchView, practitioners can optimise drug utilisation, avoid residual neuromuscular block, and prevent the adverse effect.
